209 related articles for article (PubMed ID: 18475300)
1. Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy.
Yoshikawa R; Nakano Y; Tao L; Koishi K; Matsumoto T; Sasako M; Tsujimura T; Hashimoto-Tamaoki T; Fujiwara Y
Br J Cancer; 2008 May; 98(10):1670-4. PubMed ID: 18475300
[TBL] [Abstract][Full Text] [Related]
2. The oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapy.
Yoshikawa R; Tsujimura T; Tao L; Kamikonya N; Fujiwara Y
BMC Cancer; 2012 Oct; 12():461. PubMed ID: 23046527
[TBL] [Abstract][Full Text] [Related]
3. Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma.
Mori Y; Okumura T; Tsunoda S; Sakai Y; Shimada Y
Oncology; 2006; 70(5):378-89. PubMed ID: 17179732
[TBL] [Abstract][Full Text] [Related]
4. Correlation of hedgehog signal activation with chemoradiotherapy sensitivity and survival in esophageal squamous cell carcinomas.
Zhu W; You Z; Li T; Yu C; Tao G; Hu M; Chen X
Jpn J Clin Oncol; 2011 Mar; 41(3):386-93. PubMed ID: 21127038
[TBL] [Abstract][Full Text] [Related]
5. Interplay between the NF‑κB and hedgehog signaling pathways predicts prognosis in esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy.
Wei L; Yan N; Sun L; Bao C; Li D
Int J Mol Med; 2018 May; 41(5):2961-2967. PubMed ID: 29393402
[TBL] [Abstract][Full Text] [Related]
6. Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer.
Lim SH; Hong M; Ahn S; Choi YL; Kim KM; Oh D; Ahn YC; Jung SH; Ahn MJ; Park K; Zo JI; Shim YM; Sun JM
Eur J Cancer; 2016 Jan; 52():1-9. PubMed ID: 26623522
[TBL] [Abstract][Full Text] [Related]
7. Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients.
Wadhwa R; Wang X; Baladandayuthapani V; Liu B; Shiozaki H; Shimodaira Y; Lin Q; Elimova E; Hofstetter WL; Swisher SG; Rice DC; Maru DM; Kalhor N; Bhutani MS; Weston B; Lee JH; Skinner HD; Scott AW; Kaya DM; Harada K; Berry D; Song S; Ajani JA
Br J Cancer; 2017 Aug; 117(5):648-655. PubMed ID: 28728163
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma.
He LR; Liu MZ; Li BK; Rao HL; Deng HX; Guan XY; Zeng YX; Xie D
Cancer Sci; 2009 Sep; 100(9):1591-6. PubMed ID: 19552757
[TBL] [Abstract][Full Text] [Related]
9. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
10. HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma.
Yan M; Wang L; Zuo H; Zhang Z; Chen W; Mao L; Zhang P
Oral Oncol; 2011 Jun; 47(6):504-9. PubMed ID: 21536478
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence.
Yoshikawa R; Fujiwara Y; Koishi K; Kojima S; Matsumoto T; Yanagi H; Yamamura T; Hashimoto-Tamaoki T; Nishigami T; Tsujimura T
World J Gastroenterol; 2007 Apr; 13(16):2283-8. PubMed ID: 17511025
[TBL] [Abstract][Full Text] [Related]
12. Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus.
Nakanoko T; Saeki H; Morita M; Nakashima Y; Ando K; Oki E; Ohga T; Kakeji Y; Toh Y; Maehara Y
Ann Surg Oncol; 2014 Feb; 21(2):597-604. PubMed ID: 24065387
[TBL] [Abstract][Full Text] [Related]
13. Correlation Between Biomarker Candidate Proteins with the Effect of Neoadjuvant Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma.
Noda M; Okumura H; Uchikado Y; Omoto I; Sasaki K; Kita Y; Mori S; Owaki T; Arigami T; Uenosono Y; Nakajo A; Kijima Y; Ishigami S; Maemura K; Natsugoe S
Ann Surg Oncol; 2018 Feb; 25(2):449-455. PubMed ID: 29188501
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of
Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of the expression of Hedgehog proteins in cervical carcinoma FIGO stages I-IV treated with radiotherapy or chemoradiotherapy.
Bohr Mordhorst L; Ahlin C; Sorbe B
Gynecol Oncol; 2014 Nov; 135(2):305-11. PubMed ID: 25158038
[TBL] [Abstract][Full Text] [Related]
17. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
Yang Z; Cui Y; Ni W; Kim S; Xuan Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
[TBL] [Abstract][Full Text] [Related]
18. Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome.
He HC; Chen JH; Chen XB; Qin GQ; Cai C; Liang YX; Han ZD; Dai QS; Chen YR; Zeng GH; Zhu JG; Jiang FN; Zhong WD
Pathol Oncol Res; 2012 Apr; 18(2):349-55. PubMed ID: 21861243
[TBL] [Abstract][Full Text] [Related]
19. Msi2 plays a carcinogenic role in esophageal squamous cell carcinoma via regulation of the Wnt/β-catenin and Hedgehog signaling pathways.
Li Z; Jin H; Mao G; Wu L; Guo Q
Exp Cell Res; 2017 Dec; 361(1):170-177. PubMed ID: 29054489
[TBL] [Abstract][Full Text] [Related]
20. Impact of Sonic Hedgehog Pathway Expression on Outcome in HPV Negative Head and Neck Carcinoma Patients after Surgery and Adjuvant Radiotherapy.
Enzenhofer E; Parzefall T; Haymerle G; Schneider S; Kadletz L; Heiduschka G; Pammer J; Oberndorfer F; Wrba F; Loader B; Grasl MC; Perisanidis C; Erovic BM
PLoS One; 2016; 11(12):e0167665. PubMed ID: 27918595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
